(Q45858411)

17 December 2017

title

Endostatin gene therapy on murine lung metastases model utilizing cationic vector-mediated intravenous gene delivery (English)

1 reference

17 December 2017

0 references

Nakashima Y

1

1 reference

17 December 2017

Yano M

2

1 reference

17 December 2017

Kobayashi Y

3

1 reference

17 December 2017

Moriyama S

4

1 reference

17 December 2017

Sasaki H

5

1 reference

17 December 2017

Toyama T

6

1 reference

17 December 2017

Yamashita H

7

1 reference

17 December 2017

Fukai I

8

1 reference

17 December 2017

Iwase H

9

1 reference

17 December 2017

Yamakawa Y

10

1 reference

17 December 2017

Fujii Y

11

1 reference

17 December 2017

publication date

1 January 2003

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

10

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

123-130

1 reference

17 December 2017

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Improving protein therapeutics with sustained-release formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Antiangiogenic gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Gene therapy strategies for tumor antiangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Transgene expression after adenovirus-mediated retransfection of rat lungs is increased and prolonged by transplant immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Gene transfer in vivo with DNA-liposome complexes: lack of autoimmunity and gonadal localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Parenteral gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Systemic gene expression after intravenous DNA delivery into adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Cationic liposome-mediated intravenous gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Systemic gene therapy: biodistribution and long-term expression of a transgene in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Characterization of liposome-mediated gene delivery: expression, stability and pharmacokinetics of plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Comparison between intratracheal and intravenous administration of liposome-DNA complexes for cystic fibrosis lung gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Polyethylenimine-based intravenous delivery of transgenes to mouse lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Cholesterol enhances cationic liposome-mediated DNA transfection of human respiratory epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Cationic liposome-mediated transfection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Liver-directed gene transfer vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

Effects of angiogenesis inhibitors on multistage carcinogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

The body as a manufacturer of endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

7 January 2021

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

7 January 2021

Gene Transfer In Vivo with DNA–Liposome Complexes: Safety and Acute Toxicity in Mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

7 January 2021

Toxicity of cationic liposome-DNA complex in lung isografts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301856

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301856

1 reference

17 December 2017

Dimensions Publication ID

1019141009

0 references

1 reference

17 December 2017